Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Revenue

Sunshine Lake Pharma had revenue of 1.08B CNY in the half year ending June 30, 2026, a decrease of -58.35%. This brings the company's total for the last twelve months to 3.95B, up 17.13% year-over-year. In the year 2025, Sunshine Lake Pharma had annual revenue of 4.82B with 19.81% growth. That makes Sunshine Lake Pharma the 10,389th largest company in the world by revenue and 630th in Hong Kong.

• Revenue (ttm): 3.95B CNY
• Revenue Growth: +17.13%
• P/S Ratio: 5.10
• Revenue / Employee: 627.51K CNY
• Employees: 6,299
• Market Cap: 23.30B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Peoples Republic of China (PRC) 4.72B 98.1%
• Overseas 90.28M 1.9%

Fiscal year ended Dec 31, 2025 See the full Sunshine Lake Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.82B	796.16M	19.81%
Dec 31, 2024	4.02B	-2.28B	-36.15%
Dec 31, 2023	6.29B	2.55B	68.08%
Dec 31, 2022	3.74B	2.83B	309.83%
Dec 31, 2021	913.79M	-1.43B	-61.08%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 17, 2026

Data Sources Report a data error